Virginia Oncology Associates — Elizabeth City, North Carolina

Public research footprint of Virginia Oncology Associates, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Lung Cancer · Stage IIA Breast Cancer AJCC v6 and v7 · Stage IIB Breast Cancer AJCC v6 and v7 · Prostate Cancer

Recently updated registry entries

NCT00977574 — Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… (Active Not Recruiting)
NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)
NCT07573215 — Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic… (Available)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Virginia Oncology Associates?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.